Intermetatarsal Bursitis Treatment, Foot, Injection, vs Morton's Neuroma, ICD-10

Intermetatarsal Bursitis:

• What is Intermetatarsal Bursitis?
• Intermetatarsal Bursitis Treatment
• Intermetatarsal Bursitis Foot
• Intermetatarsal Bursitis Injection
• Intermetatarsal Bursitis vs Morton's Neuroma
• Intermetatarsal Bursitis ICD-10

What is Intermetatarsal Bursitis?

Intermetatarsal bursitis is an inflammatory condition affecting one of the small fluid-filled bursae located between the metatarsal bones in the forefoot. These bursae act as natural cushions that reduce friction between bones, ligaments, tendons, and soft tissues during walking, running, and standing. When excessive pressure, repetitive stress, injury, or abnormal foot mechanics irritate these bursae, they become swollen and inflamed, leading to pain in the ball of the foot. The condition most commonly develops between the third and fourth metatarsal heads, although it may occur in other intermetatarsal spaces. Patients often describe a burning, aching, or sharp pain that worsens while walking, wearing tight shoes, or participating in sports. Some individuals also report a sensation similar to walking on a pebble or folded sock inside the shoe. Because these symptoms overlap with several other forefoot disorders, especially Morton's neuroma, careful clinical examination and imaging are often required to establish the correct diagnosis.

The condition can affect people of all ages but is more frequently seen in runners, athletes, dancers, and individuals who spend long hours standing. Women may develop intermetatarsal bursitis more commonly because of narrow or high-heeled footwear that increases pressure on the forefoot. Flat feet, high arches, rheumatoid arthritis, gout, diabetes, obesity, and repetitive impact activities may also increase the risk of developing bursitis. During a physical examination, tenderness between the metatarsal heads, swelling, and pain with compression of the forefoot are common findings. Ultrasound and MRI are particularly useful because they can directly visualize the inflamed bursa and distinguish it from nearby nerve abnormalities. Early recognition is important since prompt conservative treatment often leads to complete recovery without surgery, while untreated inflammation may become chronic and significantly interfere with daily activities and sports participation.

Intermetatarsal Bursitis Treatment

Treatment for intermetatarsal bursitis usually begins with conservative measures aimed at reducing inflammation and relieving pressure on the affected bursa. Patients are commonly advised to modify activities that worsen symptoms, particularly running, jumping, or prolonged standing. Wearing shoes with a wide toe box and adequate cushioning can significantly decrease pressure between the metatarsal heads. Orthotic devices, metatarsal pads, and custom shoe inserts help redistribute weight away from the inflamed area and improve foot mechanics. Ice application several times daily for fifteen to twenty minutes can reduce swelling, while nonsteroidal anti-inflammatory drugs (NSAIDs), if appropriate, may relieve pain and inflammation. Stretching exercises for the calf muscles, Achilles tendon, and plantar fascia, along with strengthening exercises for the intrinsic foot muscles, may improve biomechanics and reduce recurrence. Many patients experience gradual improvement over several weeks when these conservative strategies are followed consistently.

If symptoms continue despite initial treatment, additional therapies may be recommended. Physical therapy often includes manual mobilization techniques, gait training, therapeutic ultrasound, balance exercises, and progressive strengthening programs. Ultrasound-guided aspiration of an enlarged bursa may occasionally be considered when excessive fluid accumulation contributes to discomfort. For persistent inflammation, corticosteroid injections may provide substantial pain relief while allowing rehabilitation to continue. Rarely, surgery becomes necessary when conservative management fails after several months or when associated conditions, such as severe deformities or chronic bursitis, prevent normal function. Surgical procedures generally involve removal of the inflamed bursa and correction of any underlying mechanical abnormalities. Most patients recover successfully with non-operative treatment, especially when contributing footwear and biomechanical factors are addressed early in the disease process.

Intermetatarsal Bursitis Foot

Intermetatarsal bursitis primarily affects the forefoot, specifically the spaces located between adjacent metatarsal heads. Patients frequently experience pain in the ball of the foot that worsens while walking barefoot on hard surfaces or wearing tight shoes. Swelling may be subtle, but some individuals notice fullness between the toes or tenderness when squeezing the forefoot. Unlike many other foot conditions, the discomfort often improves with rest and becomes worse during weight-bearing activities. Individuals may unconsciously shift their weight toward the outside of the foot to reduce pressure, which can eventually contribute to altered gait mechanics and secondary pain in the ankle, knee, or hip. In some cases, inflammation extends to surrounding tissues, making toe movement uncomfortable and causing mild stiffness during prolonged walking.

A detailed foot examination is essential for identifying the exact location of symptoms and excluding other causes of forefoot pain. Physicians assess tenderness, swelling, toe alignment, range of motion, and gait while comparing both feet. Diagnostic ultrasound is particularly helpful because it can detect small fluid collections within the inflamed bursa and demonstrate tenderness during dynamic examination. MRI provides even greater detail by showing the relationship between the bursa, plantar plate, tendons, ligaments, and digital nerves. Recognizing the anatomical structures involved helps clinicians select the most appropriate treatment strategy while avoiding unnecessary interventions. Good footwear, weight management, activity modification, and early medical evaluation all contribute to preserving long-term foot function and preventing recurrent episodes.

Intermetatarsal Bursitis Injection

Corticosteroid injections are frequently considered when conservative treatment does not adequately relieve symptoms after several weeks or months. These injections combine a corticosteroid medication with a local anesthetic and are usually performed under ultrasound guidance to improve placement accuracy. Delivering medication directly into the inflamed bursa helps reduce swelling, decrease inflammatory activity, and provide significant pain relief. Many patients notice improvement within a few days, although the full effect may take one to two weeks. Ultrasound guidance also minimizes the risk of injecting nearby nerves or tendons and increases the likelihood of successful treatment. During the procedure, the physician cleans the skin, positions the ultrasound probe, inserts a fine needle into the bursa, and slowly injects the medication while observing its distribution on the screen.

Although corticosteroid injections are generally safe, they are not appropriate for everyone and should be used carefully. Possible side effects include temporary soreness, skin discoloration, fat pad thinning, infection, bleeding, or transient elevation of blood glucose in people with diabetes. Repeated injections into the same area are usually limited because excessive steroid exposure may weaken surrounding tissues over time. Following an injection, patients are commonly advised to rest the foot for one to two days before gradually returning to normal activities. Combining injections with proper footwear, orthotics, stretching exercises, and physical therapy provides the best chance of long-term symptom control. If pain returns despite appropriate injection therapy, additional evaluation may be necessary to rule out Morton's neuroma, stress fractures, inflammatory arthritis, or other forefoot disorders.

Intermetatarsal Bursitis vs Morton's Neuroma

Intermetatarsal bursitis and Morton's neuroma frequently produce similar symptoms, making differentiation challenging without imaging. Intermetatarsal bursitis is inflammation of a fluid-filled bursa located between the metatarsal heads, whereas Morton's neuroma is enlargement and irritation of the common digital nerve, usually between the third and fourth toes. Patients with bursitis often experience aching pain, localized swelling, and tenderness over the affected intermetatarsal space. Those with Morton's neuroma are more likely to report burning pain, numbness, tingling, or electric shock-like sensations that radiate into the toes. Both conditions may worsen with tight footwear and improve after removing shoes, which further complicates diagnosis. Physical examination techniques, including forefoot compression and palpation, provide useful clues but are not always definitive.

Modern imaging greatly improves diagnostic accuracy. Ultrasound can distinguish an enlarged fluid-filled bursa from a thickened digital nerve, while MRI clearly demonstrates both conditions and any associated soft tissue abnormalities. Treatment overlaps considerably because both disorders initially respond to shoe modifications, orthotics, activity changes, anti-inflammatory medication, and physical therapy. However, persistent Morton's neuroma may eventually require nerve-targeted injections or surgical excision, whereas chronic bursitis typically focuses on managing inflammation or removing the inflamed bursa if conservative therapy fails. Correct diagnosis is therefore essential because it directs appropriate treatment and improves long-term outcomes while avoiding unnecessary procedures.

Intermetatarsal Bursitis ICD-10

There is no single ICD-10-CM diagnosis code that specifically names "intermetatarsal bursitis." Instead, coding generally depends on the affected foot and the provider's documented diagnosis. Many clinicians use codes within the bursitis category of the foot or other specified soft tissue disorders when documentation supports those diagnoses. Accurate coding requires careful review of the physician's notes, imaging findings, and payer-specific guidance. Because coding standards are updated periodically, healthcare providers and medical coders should verify the most current ICD-10-CM coding guidance before submitting insurance claims.

When documenting intermetatarsal bursitis, clinicians should include the affected side (right, left, or bilateral), duration of symptoms, underlying cause if known, imaging findings, associated conditions such as Morton's neuroma or rheumatoid arthritis, and all treatments provided. Thorough documentation improves coding accuracy, supports medical necessity for imaging or injections, and facilitates communication among healthcare professionals. If uncertainty exists regarding the most appropriate ICD-10 code, consultation with certified medical coders or current coding manuals is recommended to ensure compliance with payer requirements and accurate reimbursement.